David Gallego-Ortega

David Gallego-Ortega

UNVERIFIED PROFILE

Are you David Gallego-Ortega?   Register this Author

Register author
David Gallego-Ortega

David Gallego-Ortega

Publications by authors named "David Gallego-Ortega"

Are you David Gallego-Ortega?   Register this Author

34Publications

927Reads

10Profile Views

Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology.

Front Immunol 2018 12;9:2582. Epub 2018 Nov 12.

St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.02582DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240655PMC
October 2019

Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion.

Cell Adh Migr 2018 21;12(6):513-523. Epub 2017 Dec 21.

a Cancer Research Division , Garvan Institute of Medical Research and the Kinghorn Cancer Centre , 384 Victoria Street, Darlinghurst , NSW , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19336918.2017.1393591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363037PMC
July 2019

Droplet-based single cell RNAseq tools: a practical guide.

Lab Chip 2019 05;19(10):1706-1727

Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=C8LC01239C
Publisher Site
http://dx.doi.org/10.1039/c8lc01239cDOI Listing
May 2019

Static droplet array for culturing single live adherent cells in an isolated chemical microenvironment.

Lab Chip 2018 07;18(15):2156-2166

School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, NSW 2052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c8lc00403jDOI Listing
July 2018

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.

Endocr Relat Cancer 2017 07;24(7):X1

Tumour Development GroupThe Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0404eDOI Listing
July 2017

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.

Endocr Relat Cancer 2017 04 13;24(4):R123-R144. Epub 2017 Feb 13.

Tumour Development GroupThe Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0404DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425956PMC
April 2017

ELF5 isoform expression is tissue-specific and significantly altered in cancer.

Breast Cancer Res 2016 Jan 7;18(1). Epub 2016 Jan 7.

Cancer Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Sydney, NSW, 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-015-0666-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704400PMC
January 2016

ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype.

Nat Commun 2015 Mar 27;6:6548. Epub 2015 Mar 27.

1] The Kinghorn Cancer Centre &Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia [2] St Vincent's Clinical School, Faculty of Medicine, UNSW, Kensington, New South Wales 2033, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7548DOI Listing
March 2015

The mammary cellular hierarchy and breast cancer.

Cell Mol Life Sci 2014 Nov 31;71(22):4301-24. Epub 2014 Jul 31.

Cancer Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, 384 Victoria St., Darlinghurst, NSW, 2010, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00018-014-1674-4
Publisher Site
http://dx.doi.org/10.1007/s00018-014-1674-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207940PMC
November 2014

BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer.

Mol Cancer Ther 2013 Sep 16;12(9):1874-85. Epub 2013 Jul 16.

Corresponding Author: Andrew Stone, Garvan Institute of Medical Research, L9 TKCC, 370 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0012DOI Listing
September 2013

Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells.

Development 2013 Apr 5;140(7):1397-401. Epub 2013 Mar 5.

Cancer Research Program, Garvan Institute of Medical Research, 348 Victoria Street, and St Vincent's Hospital Clinical School, University of New South Wales, Darlinghurst NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dev.biologists.org/cgi/doi/10.1242/dev.088948
Publisher Site
http://dx.doi.org/10.1242/dev.088948DOI Listing
April 2013

Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway.

Cancer Res 2013 Mar 1;73(6):1969-80. Epub 2013 Feb 1.

Cancer Research Program, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-1472DOI Listing
March 2013

Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.

Stem Cells 2011 Oct;29(10):1611-9

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.706DOI Listing
October 2011

Evidence of p38γ and p38δ involvement in cell transformation processes.

Carcinogenesis 2011 Jul 10;32(7):1093-9. Epub 2011 May 10.

Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, 28049 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgr079DOI Listing
July 2011

Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells.

Mol Cancer 2009 Dec 31;8:131. Epub 2009 Dec 31.

Singapore OncoGenome Project, Institute of Medical Biology, A*STAR, 8A Biomedical Grove, 06-06 Immunos, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-8-131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806310PMC
December 2009

Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy.

Int J Biochem Cell Biol 2008 19;40(9):1753-63. Epub 2008 Jan 19.

Translational Oncology Unit CSIC-UAM-La Paz, Centro Nacional de Biotecnología (CNB), Darwin 3, 28049 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2008.01.013DOI Listing
September 2008

Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis.

Cancer Res 2005 Jul;65(13):5647-53

Unidad de Oncología Translacional, Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Cientificas-UAM, Spain.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-04-4416DOI Listing
July 2005